Skip to content

Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.

Randomized controlled trial · J Am Acad Dermatol · 2024. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 37690021

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.

Huang WK, Hsu HC, Yang TS et al.
J Am Acad Dermatol · 2024

PubMed ID
37690021
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.